The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients

Status Completed

Clinical Trial Summary

This research is a clinical trial of administering mesenchymal stem cell secretome to lupus patients.

Clinical Trial Description

This research is experimental. The study was conducted on 30 SLE patient subjects. the treatment group who got the mesenchymal stem cell secretome on the 1st, 2nd day, 3rd, 4th, 5th, 6th, 7th, 14th, 21st, and 28th days. ESR, hs-CRP, C3, C4, interlukin 6, anti-ds-DNA antibody, MEX SLEDAI score, and assessment of drug side effects before and after therapy were collected. Statistical test with paired difference test with p < 0.05 ;

Study Design

Related Conditions & MeSH terms

Lupus Erythematosus

Clinical Trial Details

NCT number	NCT05921058
Study type	Interventional
Source	Universitas Sebelas Maret
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	August 1, 2022
Completion date	March 9, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03543839` - Trial of Belimumab in Early Lupus	Phase 4
Terminated	`NCT02080195` - Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)	Phase 1/Phase 2
Completed	`NCT03098823` - A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE	Phase 4
Recruiting	`NCT03562065` - Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord	Phase 1/Phase 2
Recruiting	`NCT05545839` - Transition to Adulthood Through Coaching and Empowerment in Rheumatology	N/A
Completed	`NCT05098600` - The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
Completed	`NCT04128579` - Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis	Phase 1
Recruiting	`NCT06161363` - Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
Completed	`NCT03421184` - Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus	N/A
Not yet recruiting	`NCT02891213` - Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.	N/A
Completed	`NCT01686555` - A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)	Phase 1
Active, not recruiting	`NCT04018222` - Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Recruiting	`NCT06294236` - Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)	Phase 1
Completed	`NCT02747277` - Analysis of B Cells From Autoimmune Individuals
Recruiting	`NCT04213690` - A Pilot Study to Explore the Role of Gut Flora in Lupus
Recruiting	`NCT03913754` - Psycho-social Consequences of Systemic Lupus Erythematosus
Recruiting	`NCT06072287` - The Living With a Long-Term Condition Study
Completed	`NCT02455089` - Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus	N/A
Completed	`NCT04089930` - Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients
Completed	`NCT05945784` - Exploring Accessible Beauty for Individuals With Upper Extremity Deficits